Investing & Markets

Make better decisions with investing tips, technical analysis, market commentary, and more

Personal Finance

Make more, save more, spend smarter, and keep more of what you earn

Business News

Stock market news & analysis

Biotech

Allos Therapeutics Offering (NASDAQ:ALTH)

By Jyotsna Ramani on 10/08/2009 – 9:00 am PDTLeave a Comment

Allos Therapeutics has announced on Wednesday morning that they will be expanding the share offerings and will now sell around 14 million shares for $7.10 per share. On Monday, Allos Therapeutics has already announced that they have so far sold 12.65 million shares. However, the company has not provided any reasons behind why they are expanding their share offerings and prices of shares too.

Related Articles:

  1. Sangamo BioSciences Offering (NASDAQ:SGMO)
  2. Shares of Amicus Drop (NASDAQ:FOLD)
  3. Bionovo’s New Offering (NASDAQ:BNVI)
  4. Chelsea Therapeutics Rallies on Droxidopa Data (NASDAQ:CHTP)
  5. Folotyn drug gets FDA approval (Nasdaq:ALTH)

Pages: 1 2

Comments are closed.